Pieter A. Vriesendorp

Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Arend F. L. Schinkel, Max Liebregts et al. · Circulation Arrhythmia and Electrophysiology · 2015 · 138 citations

Medicine, Cardiology, Clinical Cardiology +16

Long-Term Outcomes After Medical and Invasive Treatment in Patients With Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Max Liebregts, Robbert Steggerda et al. · JACC Heart Failure · 2014 · 120 citations

Medicine, Cardiology, Internal Medicine +8

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications

Pieter A. Vriesendorp, Arend F. L. Schinkel, Johan Van Cleemput et al. · American Heart Journal · 2013 · 103 citations

Medicine, Cardiology, Internal Medicine +15

Long-Term Benefit of Myectomy and Anterior Mitral Leaflet Extension in Obstructive Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Arend F. L. Schinkel, Osama Soliman et al. · The American Journal of Cardiology · 2014 · 83 citations

Medicine, Cardiology, Surgery +8

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy

Max Liebregts, Lothar Faber, Morten K. Jensen et al. · JACC: Cardiovascular Interventions · 2017 · 67 citations · Full text

Medicine, Cardiology, Internal Medicine +5